Who are the key players in the rituxan rituximab monoclonal antibody market?

Some of the key players are NHL, Key, Pfizer Inc, Amgen Inc, Others.

BUY CHAPTERS

Global Rituxan (Rituximab) Monoclonal Antibody Market Research Report 2023

Q: How big is the rituxan rituximab monoclonal antibody market?

Children 6 months of age and older with mature Bcell NonHodgkins Lymphoma NHL and mature Bcell acute leukemia BAL in combination with chemotherapy medicines.According to QYResearchs new survey global Rituxan Rituximab Monoclonal Antibody market is projected to reach US 5306.7 million in 2029 increasing from US 4125 million in 2022 with the CAGR of 3.5 during the period of 2023 to 2029.

Code: QYRE-Auto-15Y14716

Report

June 2023

Pages:73

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Rituxan (Rituximab) Monoclonal Antibody Market Size

According to QYResearch’s new survey, global Rituxan (Rituximab) Monoclonal Antibody market is projected to reach US$ 5306.7 million in 2029, increasing from US$ 4125 million in 2022, with the CAGR of 3.5% during the period of 2023 to 2029.

Rituxan (Rituximab) Monoclonal Antibody Market

RITUXAN® (rituximab) is a prescription medicine used to treat: Adults with Non-Hodgkin's Lymphoma (NHL): alone or with other chemotherapy medicines. Children 6 months of age and older with mature B-cell Non-Hodgkin's Lymphoma (NHL) and mature B-cell acute leukemia (B-AL): in combination with chemotherapy medicines.

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Rituxan (Rituximab) Monoclonal Antibody market research.

Key manufacturers engaged in the Rituxan (Rituximab) Monoclonal Antibody industry include Roche, Teva, Pfizer and Amgen, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Rituxan (Rituximab) Monoclonal Antibody were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Rituxan (Rituximab) Monoclonal Antibody market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Rituxan (Rituximab) Monoclonal Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Rituxan (Rituximab) Monoclonal Antibody Market Report

Report Metric	Details
Report Name	Rituxan (Rituximab) Monoclonal Antibody Market
Accounted market size in 2022	US$ 4125 million
Forecasted market size in 2029	US$ 5306.7 million
CAGR	3.5%
Base Year	2022
Forecasted years	2023 - 2029
Segment by Type	Brand Biosimilar
Segment by Application	Child Adult
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Roche, Teva, Pfizer, Amgen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

How fast is Rituxan (Rituximab) Monoclonal Antibody Market market growing?

Ans: The Rituxan (Rituximab) Monoclonal Antibody Market market witnessing a CAGR of 3.5% during the forecast period 2023-2029.

What is the Rituxan (Rituximab) Monoclonal Antibody Market market size in 2029?

Ans: According to QYResearch’s new survey, global Rituxan (Rituximab) Monoclonal Antibody market is projected to reach US$ 5306.7 million in 2029, increasing from US$ 4125 million in 2022, with the CAGR of 3.5% during the period of 2023 to 2029.

1 Rituxan (Rituximab) Monoclonal Antibody Market Overview

1.1 Product Overview and Scope of Rituxan (Rituximab) Monoclonal Antibody

1.2 Rituxan (Rituximab) Monoclonal Antibody Segment by Type

1.2.1 Global Rituxan (Rituximab) Monoclonal Antibody Market Value Comparison by Type (2023-2029)

1.2.2 Brand

1.2.3 Biosimilar

1.3 Rituxan (Rituximab) Monoclonal Antibody Segment by Application

1.3.1 Global Rituxan (Rituximab) Monoclonal Antibody Market Value by Application: (2023-2029)

1.3.2 Child

1.3.3 Adult

1.4 Global Rituxan (Rituximab) Monoclonal Antibody Market Size Estimates and Forecasts

1.4.1 Global Rituxan (Rituximab) Monoclonal Antibody Revenue 2018-2029

1.4.2 Global Rituxan (Rituximab) Monoclonal Antibody Sales 2018-2029

1.4.3 Global Rituxan (Rituximab) Monoclonal Antibody Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2 Rituxan (Rituximab) Monoclonal Antibody Market Competition by Manufacturers

2.1 Global Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Manufacturers (2018-2023)

2.2 Global Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Rituxan (Rituximab) Monoclonal Antibody Average Price by Manufacturers (2018-2023)

2.4 Global Rituxan (Rituximab) Monoclonal Antibody Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Rituxan (Rituximab) Monoclonal Antibody, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Rituxan (Rituximab) Monoclonal Antibody, Product Type & Application

2.7 Rituxan (Rituximab) Monoclonal Antibody Market Competitive Situation and Trends

2.7.1 Rituxan (Rituximab) Monoclonal Antibody Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Rituxan (Rituximab) Monoclonal Antibody Players Market Share by Revenue

2.7.3 Global Rituxan (Rituximab) Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Rituxan (Rituximab) Monoclonal Antibody Retrospective Market Scenario by Region

3.1 Global Rituxan (Rituximab) Monoclonal Antibody Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Rituxan (Rituximab) Monoclonal Antibody Global Rituxan (Rituximab) Monoclonal Antibody Sales by Region: 2018-2029

3.2.1 Global Rituxan (Rituximab) Monoclonal Antibody Sales by Region: 2018-2023

3.2.2 Global Rituxan (Rituximab) Monoclonal Antibody Sales by Region: 2024-2029

3.3 Global Rituxan (Rituximab) Monoclonal Antibody Global Rituxan (Rituximab) Monoclonal Antibody Revenue by Region: 2018-2029

3.3.1 Global Rituxan (Rituximab) Monoclonal Antibody Revenue by Region: 2018-2023

3.3.2 Global Rituxan (Rituximab) Monoclonal Antibody Revenue by Region: 2024-2029

3.4 North America Rituxan (Rituximab) Monoclonal Antibody Market Facts & Figures by Country

3.4.1 North America Rituxan (Rituximab) Monoclonal Antibody Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Rituxan (Rituximab) Monoclonal Antibody Sales by Country (2018-2029)

3.4.3 North America Rituxan (Rituximab) Monoclonal Antibody Revenue by Country (2018-2029)

3.4.4 United States

3.4.5 Canada

3.5 Europe Rituxan (Rituximab) Monoclonal Antibody Market Facts & Figures by Country

3.5.1 Europe Rituxan (Rituximab) Monoclonal Antibody Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Rituxan (Rituximab) Monoclonal Antibody Sales by Country (2018-2029)

3.5.3 Europe Rituxan (Rituximab) Monoclonal Antibody Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Rituxan (Rituximab) Monoclonal Antibody Market Facts & Figures by Country

3.6.1 Asia Pacific Rituxan (Rituximab) Monoclonal Antibody Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Rituxan (Rituximab) Monoclonal Antibody Sales by Country (2018-2029)

3.6.3 Asia Pacific Rituxan (Rituximab) Monoclonal Antibody Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Rituxan (Rituximab) Monoclonal Antibody Market Facts & Figures by Country

3.7.1 Latin America Rituxan (Rituximab) Monoclonal Antibody Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Rituxan (Rituximab) Monoclonal Antibody Sales by Country (2018-2029)

3.7.3 Latin America Rituxan (Rituximab) Monoclonal Antibody Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Rituxan (Rituximab) Monoclonal Antibody Market Facts & Figures by Country

3.8.1 Middle East and Africa Rituxan (Rituximab) Monoclonal Antibody Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Rituxan (Rituximab) Monoclonal Antibody Sales by Country (2018-2029)

3.8.3 Middle East and Africa Rituxan (Rituximab) Monoclonal Antibody Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Rituxan (Rituximab) Monoclonal Antibody Sales by Type (2018-2029)

4.1.1 Global Rituxan (Rituximab) Monoclonal Antibody Sales by Type (2018-2023)

4.1.2 Global Rituxan (Rituximab) Monoclonal Antibody Sales by Type (2024-2029)

4.1.3 Global Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Type (2018-2029)

4.2 Global Rituxan (Rituximab) Monoclonal Antibody Revenue by Type (2018-2029)

4.2.1 Global Rituxan (Rituximab) Monoclonal Antibody Revenue by Type (2018-2023)

4.2.2 Global Rituxan (Rituximab) Monoclonal Antibody Revenue by Type (2024-2029)

4.2.3 Global Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Type (2018-2029)

4.3 Global Rituxan (Rituximab) Monoclonal Antibody Price by Type (2018-2029)

5 Segment by Application

5.1 Global Rituxan (Rituximab) Monoclonal Antibody Sales by Application (2018-2029)

5.1.1 Global Rituxan (Rituximab) Monoclonal Antibody Sales by Application (2018-2023)

5.1.2 Global Rituxan (Rituximab) Monoclonal Antibody Sales by Application (2024-2029)

5.1.3 Global Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Application (2018-2029)

5.2 Global Rituxan (Rituximab) Monoclonal Antibody Revenue by Application (2018-2029)

5.2.1 Global Rituxan (Rituximab) Monoclonal Antibody Revenue by Application (2018-2023)

5.2.2 Global Rituxan (Rituximab) Monoclonal Antibody Revenue by Application (2024-2029)

5.2.3 Global Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Application (2018-2029)

5.3 Global Rituxan (Rituximab) Monoclonal Antibody Price by Application (2018-2029)

6 Key Companies Profiled

6.1 Roche

6.1.1 Roche Corporation Information

6.1.2 Roche Description and Business Overview

6.1.3 Roche Rituxan (Rituximab) Monoclonal Antibody Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Roche Rituxan (Rituximab) Monoclonal Antibody Product Portfolio

6.1.5 Roche Recent Developments/Updates

6.2 Teva

6.2.1 Teva Corporation Information

6.2.2 Teva Description and Business Overview

6.2.3 Teva Rituxan (Rituximab) Monoclonal Antibody Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Teva Rituxan (Rituximab) Monoclonal Antibody Product Portfolio

6.2.5 Teva Recent Developments/Updates

6.3 Pfizer

6.3.1 Pfizer Corporation Information

6.3.2 Pfizer Description and Business Overview

6.3.3 Pfizer Rituxan (Rituximab) Monoclonal Antibody Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Pfizer Rituxan (Rituximab) Monoclonal Antibody Product Portfolio

6.3.5 Pfizer Recent Developments/Updates

6.4 Amgen

6.4.1 Amgen Corporation Information

6.4.2 Amgen Description and Business Overview

6.4.3 Amgen Rituxan (Rituximab) Monoclonal Antibody Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Amgen Rituxan (Rituximab) Monoclonal Antibody Product Portfolio

6.4.5 Amgen Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Rituxan (Rituximab) Monoclonal Antibody Industry Chain Analysis

7.2 Rituxan (Rituximab) Monoclonal Antibody Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Rituxan (Rituximab) Monoclonal Antibody Production Mode & Process

7.4 Rituxan (Rituximab) Monoclonal Antibody Sales and Marketing

7.4.1 Rituxan (Rituximab) Monoclonal Antibody Sales Channels

7.4.2 Rituxan (Rituximab) Monoclonal Antibody Distributors

7.5 Rituxan (Rituximab) Monoclonal Antibody Customers

8 Rituxan (Rituximab) Monoclonal Antibody Market Dynamics

8.1 Rituxan (Rituximab) Monoclonal Antibody Industry Trends

8.2 Rituxan (Rituximab) Monoclonal Antibody Market Drivers

8.3 Rituxan (Rituximab) Monoclonal Antibody Market Challenges

8.4 Rituxan (Rituximab) Monoclonal Antibody Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Rituxan (Rituximab) Monoclonal Antibody Market Value Comparison by Type (2023-2029) & (US$ Million)

Table 2. Global Rituxan (Rituximab) Monoclonal Antibody Market Value Comparison by Application (2023-2029) & (US$ Million)

Table 3. Global Rituxan (Rituximab) Monoclonal Antibody Market Competitive Situation by Manufacturers in 2022

Table 4. Global Rituxan (Rituximab) Monoclonal Antibody Sales (K Units) of Key Manufacturers (2018-2023)

Table 5. Global Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Manufacturers (2018-2023)

Table 6. Global Rituxan (Rituximab) Monoclonal Antibody Revenue (US$ Million) by Manufacturers (2018-2023)

Table 7. Global Rituxan (Rituximab) Monoclonal Antibody Revenue Share by Manufacturers (2018-2023)

Table 8. Global Market Rituxan (Rituximab) Monoclonal Antibody Average Price (US$/Unit) of Key Manufacturers (2018-2023)

Table 9. Global Key Players of Rituxan (Rituximab) Monoclonal Antibody, Industry Ranking, 2021 VS 2022 VS 2023

Table 10. Global Key Manufacturers of Rituxan (Rituximab) Monoclonal Antibody, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Rituxan (Rituximab) Monoclonal Antibody, Product Type & Application

Table 12. Global Key Manufacturers of Rituxan (Rituximab) Monoclonal Antibody, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Rituxan (Rituximab) Monoclonal Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rituxan (Rituximab) Monoclonal Antibody as of 2022)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Rituxan (Rituximab) Monoclonal Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

Table 17. Global Rituxan (Rituximab) Monoclonal Antibody Sales by Region (2018-2023) & (K Units)

Table 18. Global Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Region (2018-2023)

Table 19. Global Rituxan (Rituximab) Monoclonal Antibody Sales by Region (2024-2029) & (K Units)

Table 20. Global Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Region (2024-2029)

Table 21. Global Rituxan (Rituximab) Monoclonal Antibody Revenue by Region (2018-2023) & (US$ Million)

Table 22. Global Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Region (2018-2023)

Table 23. Global Rituxan (Rituximab) Monoclonal Antibody Revenue by Region (2024-2029) & (US$ Million)

Table 24. Global Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Region (2024-2029)

Table 25. North America Rituxan (Rituximab) Monoclonal Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 26. North America Rituxan (Rituximab) Monoclonal Antibody Sales by Country (2018-2023) & (K Units)

Table 27. North America Rituxan (Rituximab) Monoclonal Antibody Sales by Country (2024-2029) & (K Units)

Table 28. North America Rituxan (Rituximab) Monoclonal Antibody Revenue by Country (2018-2023) & (US$ Million)

Table 29. North America Rituxan (Rituximab) Monoclonal Antibody Revenue by Country (2024-2029) & (US$ Million)

Table 30. Europe Rituxan (Rituximab) Monoclonal Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 31. Europe Rituxan (Rituximab) Monoclonal Antibody Sales by Country (2018-2023) & (K Units)

Table 32. Europe Rituxan (Rituximab) Monoclonal Antibody Sales by Country (2024-2029) & (K Units)

Table 33. Europe Rituxan (Rituximab) Monoclonal Antibody Revenue by Country (2018-2023) & (US$ Million)

Table 34. Europe Rituxan (Rituximab) Monoclonal Antibody Revenue by Country (2024-2029) & (US$ Million)

Table 35. Asia Pacific Rituxan (Rituximab) Monoclonal Antibody Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

Table 36. Asia Pacific Rituxan (Rituximab) Monoclonal Antibody Sales by Region (2018-2023) & (K Units)

Table 37. Asia Pacific Rituxan (Rituximab) Monoclonal Antibody Sales by Region (2024-2029) & (K Units)

Table 38. Asia Pacific Rituxan (Rituximab) Monoclonal Antibody Revenue by Region (2018-2023) & (US$ Million)

Table 39. Asia Pacific Rituxan (Rituximab) Monoclonal Antibody Revenue by Region (2024-2029) & (US$ Million)

Table 40. Latin America Rituxan (Rituximab) Monoclonal Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 41. Latin America Rituxan (Rituximab) Monoclonal Antibody Sales by Country (2018-2023) & (K Units)

Table 42. Latin America Rituxan (Rituximab) Monoclonal Antibody Sales by Country (2024-2029) & (K Units)

Table 43. Latin America Rituxan (Rituximab) Monoclonal Antibody Revenue by Country (2018-2023) & (US$ Million)

Table 44. Latin America Rituxan (Rituximab) Monoclonal Antibody Revenue by Country (2024-2029) & (US$ Million)

Table 45. Middle East & Africa Rituxan (Rituximab) Monoclonal Antibody Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 46. Middle East & Africa Rituxan (Rituximab) Monoclonal Antibody Sales by Country (2018-2023) & (K Units)

Table 47. Middle East & Africa Rituxan (Rituximab) Monoclonal Antibody Sales by Country (2024-2029) & (K Units)

Table 48. Middle East & Africa Rituxan (Rituximab) Monoclonal Antibody Revenue by Country (2018-2023) & (US$ Million)

Table 49. Middle East & Africa Rituxan (Rituximab) Monoclonal Antibody Revenue by Country (2024-2029) & (US$ Million)

Table 50. Global Rituxan (Rituximab) Monoclonal Antibody Sales (K Units) by Type (2018-2023)

Table 51. Global Rituxan (Rituximab) Monoclonal Antibody Sales (K Units) by Type (2024-2029)

Table 52. Global Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Type (2018-2023)

Table 53. Global Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Type (2024-2029)

Table 54. Global Rituxan (Rituximab) Monoclonal Antibody Revenue (US$ Million) by Type (2018-2023)

Table 55. Global Rituxan (Rituximab) Monoclonal Antibody Revenue (US$ Million) by Type (2024-2029)

Table 56. Global Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Type (2018-2023)

Table 57. Global Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Type (2024-2029)

Table 58. Global Rituxan (Rituximab) Monoclonal Antibody Price (US$/Unit) by Type (2018-2023)

Table 59. Global Rituxan (Rituximab) Monoclonal Antibody Price (US$/Unit) by Type (2024-2029)

Table 60. Global Rituxan (Rituximab) Monoclonal Antibody Sales (K Units) by Application (2018-2023)

Table 61. Global Rituxan (Rituximab) Monoclonal Antibody Sales (K Units) by Application (2024-2029)

Table 62. Global Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Application (2018-2023)

Table 63. Global Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Application (2024-2029)

Table 64. Global Rituxan (Rituximab) Monoclonal Antibody Revenue (US$ Million) by Application (2018-2023)

Table 65. Global Rituxan (Rituximab) Monoclonal Antibody Revenue (US$ Million) by Application (2024-2029)

Table 66. Global Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Application (2018-2023)

Table 67. Global Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Application (2024-2029)

Table 68. Global Rituxan (Rituximab) Monoclonal Antibody Price (US$/Unit) by Application (2018-2023)

Table 69. Global Rituxan (Rituximab) Monoclonal Antibody Price (US$/Unit) by Application (2024-2029)

Table 70. Roche Corporation Information

Table 71. Roche Description and Business Overview

Table 72. Roche Rituxan (Rituximab) Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 73. Roche Rituxan (Rituximab) Monoclonal Antibody Product

Table 74. Roche Recent Developments/Updates

Table 75. Teva Corporation Information

Table 76. Teva Description and Business Overview

Table 77. Teva Rituxan (Rituximab) Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 78. Teva Rituxan (Rituximab) Monoclonal Antibody Product

Table 79. Teva Recent Developments/Updates

Table 80. Pfizer Corporation Information

Table 81. Pfizer Description and Business Overview

Table 82. Pfizer Rituxan (Rituximab) Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 83. Pfizer Rituxan (Rituximab) Monoclonal Antibody Product

Table 84. Pfizer Recent Developments/Updates

Table 85. Amgen Corporation Information

Table 86. Amgen Description and Business Overview

Table 87. Amgen Rituxan (Rituximab) Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 88. Amgen Rituxan (Rituximab) Monoclonal Antibody Product

Table 89. Amgen Recent Developments/Updates

Table 90. Key Raw Materials Lists

Table 91. Raw Materials Key Suppliers Lists

Table 92. Rituxan (Rituximab) Monoclonal Antibody Distributors List

Table 93. Rituxan (Rituximab) Monoclonal Antibody Customers List

Table 94. Rituxan (Rituximab) Monoclonal Antibody Market Trends

Table 95. Rituxan (Rituximab) Monoclonal Antibody Market Drivers

Table 96. Rituxan (Rituximab) Monoclonal Antibody Market Challenges

Table 97. Rituxan (Rituximab) Monoclonal Antibody Market Restraints

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Rituxan (Rituximab) Monoclonal Antibody

Figure 2. Global Rituxan (Rituximab) Monoclonal Antibody Market Value Comparison by Type (2023-2029) & (US$ Million)

Figure 3. Global Rituxan (Rituximab) Monoclonal Antibody Market Share by Type in 2022 & 2029

Figure 4. Brand Product Picture

Figure 5. Biosimilar Product Picture

Figure 6. Global Rituxan (Rituximab) Monoclonal Antibody Market Value Comparison by Application (2023-2029) & (US$ Million)

Figure 7. Global Rituxan (Rituximab) Monoclonal Antibody Market Share by Application in 2022 & 2029

Figure 8. Child

Figure 9. Adult

Figure 10. Global Rituxan (Rituximab) Monoclonal Antibody Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 11. Global Rituxan (Rituximab) Monoclonal Antibody Market Size (2018-2029) & (US$ Million)

Figure 12. Global Rituxan (Rituximab) Monoclonal Antibody Sales (2018-2029) & (K Units)

Figure 13. Global Rituxan (Rituximab) Monoclonal Antibody Average Price (US$/Unit) & (2018-2029)

Figure 14. Rituxan (Rituximab) Monoclonal Antibody Report Years Considered

Figure 15. Rituxan (Rituximab) Monoclonal Antibody Sales Share by Manufacturers in 2022

Figure 16. Global Rituxan (Rituximab) Monoclonal Antibody Revenue Share by Manufacturers in 2022

Figure 17. The Global 5 and 10 Largest Rituxan (Rituximab) Monoclonal Antibody Players: Market Share by Revenue in 2022

Figure 18. Rituxan (Rituximab) Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

Figure 19. Global Rituxan (Rituximab) Monoclonal Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

Figure 20. North America Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Country (2018-2029)

Figure 21. North America Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Country (2018-2029)

Figure 22. United States Rituxan (Rituximab) Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 23. Canada Rituxan (Rituximab) Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 24. Europe Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Country (2018-2029)

Figure 25. Europe Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Country (2018-2029)

Figure 26. Germany Rituxan (Rituximab) Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 27. France Rituxan (Rituximab) Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 28. U.K. Rituxan (Rituximab) Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 29. Italy Rituxan (Rituximab) Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 30. Russia Rituxan (Rituximab) Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 31. Asia Pacific Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Region (2018-2029)

Figure 32. Asia Pacific Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Region (2018-2029)

Figure 33. China Rituxan (Rituximab) Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 34. Japan Rituxan (Rituximab) Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 35. South Korea Rituxan (Rituximab) Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 36. India Rituxan (Rituximab) Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 37. Australia Rituxan (Rituximab) Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 38. China Taiwan Rituxan (Rituximab) Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 39. Southeast Asia Rituxan (Rituximab) Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 40. Latin America Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Country (2018-2029)

Figure 41. Latin America Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Country (2018-2029)

Figure 42. Mexico Rituxan (Rituximab) Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 43. Brazil Rituxan (Rituximab) Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 44. Argentina Rituxan (Rituximab) Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 45. Middle East & Africa Rituxan (Rituximab) Monoclonal Antibody Sales Market Share by Country (2018-2029)

Figure 46. Middle East & Africa Rituxan (Rituximab) Monoclonal Antibody Revenue Market Share by Country (2018-2029)

Figure 47. Turkey Rituxan (Rituximab) Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 48. Saudi Arabia Rituxan (Rituximab) Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 49. UAE Rituxan (Rituximab) Monoclonal Antibody Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 50. Global Sales Market Share of Rituxan (Rituximab) Monoclonal Antibody by Type (2018-2029)

Figure 51. Global Revenue Market Share of Rituxan (Rituximab) Monoclonal Antibody by Type (2018-2029)

Figure 52. Global Rituxan (Rituximab) Monoclonal Antibody Price (US$/Unit) by Type (2018-2029)

Figure 53. Global Sales Market Share of Rituxan (Rituximab) Monoclonal Antibody by Application (2018-2029)

Figure 54. Global Revenue Market Share of Rituxan (Rituximab) Monoclonal Antibody by Application (2018-2029)

Figure 55. Global Rituxan (Rituximab) Monoclonal Antibody Price (US$/Unit) by Application (2018-2029)

Figure 56. Rituxan (Rituximab) Monoclonal Antibody Value Chain

Figure 57. Rituxan (Rituximab) Monoclonal Antibody Production Process

Figure 58. Channels of Distribution (Direct Vs Distribution)

Figure 59. Distributors Profiles

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global Rituxan (Rituximab) Monoclonal Antibody Market Research Report 2023

Published Date: June 2023

Report Code: QYRE-Auto-15Y14716

Global Rituxan (Rituximab) Monoclonal Antibody Market Research Report 2023

FEATURED COMPANIES

Rituxan (Rituximab) Monoclonal Antibody Market Size

Rituxan (Rituximab) Monoclonal Antibody Market

Report Scope

Scope of Rituxan (Rituximab) Monoclonal Antibody Market Report

FAQ for this report

How fast is Rituxan (Rituximab) Monoclonal Antibody Market market growing?

What is the Rituxan (Rituximab) Monoclonal Antibody Market market size in 2029?

FEATURED COMPANIES